Melanoma is an aggressive type of skin cancer, which accounts for only 4% of skin cancer cases but causes around 75% of skin cancer deaths. Currently, there is a limited set of protein biomarkers that
BackgroundCell death patterns can give therapeutic and biological clues that facilitate the development of individualized treatments for this lethal form of skin cancer. MethodsWe employed unsupervise
